CCND1 and breast cancer: This cluster was found to be deleted in 17% of ovarian cancers, 20% of melanomas, and 22% of breast cancers; for example, miR-17-5p has tumor suppressor role in breast cancer by repressing the expression of AIBI and Cyclin D1 [48–50].